• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在诱导化疗前为急性淋巴细胞白血病患儿放置隧道式中心静脉导管。

Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.

机构信息

Department of Pediatrics, Aarhus University Hospital Skejby, Brendstrupgårdsvej, Arhus, Denmark.

出版信息

Pediatr Blood Cancer. 2010 Aug;55(2):309-13. doi: 10.1002/pbc.22530.

DOI:10.1002/pbc.22530
PMID:20582964
Abstract

BACKGROUND

Tunneled central venous catheters (CVCs) are inevitable in children with acute lymphoid leukemia (ALL). The aim of this study was to evaluate the risk of CVC-related complications in children with ALL in relation to timing of catheter placement and type of catheter.

PROCEDURE

All children hospitalized from January 2000 to March 2008 with newly diagnosed ALL and with double-lumen total implantable devices (TIDs) or tunneled external catheters (TEs) were included retrospectively. We only used data related to the patient's first catheter.

RESULTS

We included 98 children; 35 received a TID and the remaining 63 received a TE. A total number of 29,566 catheter days and 93 catheter-associated blood stream infections (CABSI) was identified. We found a CABSI rate of 3.1/1,000 catheter days (5.4/1,000 catheter days for TEs and 1.4/1,000 catheter days for TIDs, incidence rate ratio (IRR) 3.82 (95% CI 2.37-6.35) P = 0.0001). No difference was found in CABSI between neither early versus later placed TIDs (IRR = 0.99 (95% CI 0.41-2.45) P = 0.98) nor early versus later placed TEs (IRR = 0.81 (95% CI 0.40-1.86) P = 0.54). We found no difference between early and later placed catheters regarding non-elective removal (RR = 0.86 (95% CI 0.72-1.03) P = 0.09). TEs had a higher risk of non-elective removal compared with TIDs (RR = 3.95 (95% CI 1.88-8.29) P < 0.001).

CONCLUSIONS

The study did not find that children with ALL and with early placed CVCs experienced significantly more complications compared with children with late placed catheters. This study found that children with ALL and TEs experienced more complications than children with TIDs.

摘要

背景

在患有急性淋巴细胞白血病(ALL)的儿童中,经皮中心静脉导管(CVC)是不可避免的。本研究的目的是评估导管放置时间和导管类型与 ALL 儿童 CVC 相关并发症风险的关系。

过程

所有 2000 年 1 月至 2008 年 3 月期间新诊断为 ALL 且使用双腔全植入式装置(TID)或经皮外导管(TE)的住院患儿均被回顾性纳入。我们仅使用与患者首次导管相关的数据。

结果

我们纳入了 98 名患儿;35 名患儿接受 TID,其余 63 名患儿接受 TE。共识别出 29566 个导管日和 93 例导管相关血流感染(CABSI)。我们发现 CABSI 发生率为 3.1/1000 导管日(TE 为 5.4/1000 导管日,TID 为 1.4/1000 导管日,发病率比(IRR)为 3.82(95%CI 2.37-6.35),P=0.0001)。TID 早期和晚期放置之间以及 TE 早期和晚期放置之间的 CABSI 无差异(IRR=0.99(95%CI 0.41-2.45),P=0.98)。早期和晚期放置的导管之间非计划性拔除的差异也无统计学意义(RR=0.86(95%CI 0.72-1.03),P=0.09)。与 TID 相比,TE 发生非计划性拔除的风险更高(RR=3.95(95%CI 1.88-8.29),P<0.001)。

结论

本研究未发现早期放置 CVC 的 ALL 患儿与晚期放置导管的患儿相比并发症显著增加。本研究发现,ALL 患儿和 TEs 比 TIDs 患儿更容易发生并发症。

相似文献

1
Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.在诱导化疗前为急性淋巴细胞白血病患儿放置隧道式中心静脉导管。
Pediatr Blood Cancer. 2010 Aug;55(2):309-13. doi: 10.1002/pbc.22530.
2
Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.影响急性淋巴细胞白血病患儿中心静脉导管相关感染的因素:一项单中心研究结果
Pediatr Blood Cancer. 2004 Apr;42(4):325-31. doi: 10.1002/pbc.10450.
3
Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.癌症患儿及年轻成人导管相关血流感染的风险决定因素
Pediatr Blood Cancer. 2008 Jul;51(1):53-8. doi: 10.1002/pbc.21497.
4
Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.血液肿瘤性恶性疾病患儿的完全植入式中心静脉通路装置:并发症评估及发热事件发生率与无中心静脉通路装置的相似患者的比较
Pediatr Hematol Oncol. 2006 Sep;23(6):459-70. doi: 10.1080/08880010600712514.
5
Implantation of 3951 long-term central venous catheters: performances, risk analysis, and patient comfort after ultrasound-guidance introduction.3951 例长期中心静脉导管植入术:超声引导引入后的表现、风险分析和患者舒适度。
Anesth Analg. 2010 Nov;111(5):1194-201. doi: 10.1213/ANE.0b013e3181f333c1. Epub 2010 Sep 9.
6
Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.癌症患儿中心静脉导管两种不同冲洗方式的前瞻性随机试验。
J Clin Oncol. 2009 Apr 20;27(12):2059-65. doi: 10.1200/JCO.2008.19.4860. Epub 2009 Mar 9.
7
Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.低风险急性淋巴细胞白血病患儿的中心静脉置管:最佳置管类型和时机
J Clin Oncol. 2005 May 1;23(13):3024-9. doi: 10.1200/JCO.2005.12.097.
8
Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.非隧道式硅橡胶导管感染率低且耐用性长。是长期静脉通路的一种安全且具成本效益的替代选择。
Arch Intern Med. 1993 Aug 9;153(15):1791-6.
9
Exclusion of neutropenic children from implanted central venous catheter placement: impact on early catheter removal.排除中性粒细胞减少症儿童进行植入式中央静脉置管术:对早期导管移除的影响。
J Pediatr Surg. 2010 Jun;45(6):1115-9. doi: 10.1016/j.jpedsurg.2010.02.077.
10
Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia.在儿童急性淋巴细胞白血病患者中,置管时严重中性粒细胞减少不是导管相关性感染的危险因素。
Cancer. 2010 Sep 15;116(18):4368-75. doi: 10.1002/cncr.25286.

引用本文的文献

1
Impact of Perioperative Absolute Neutrophil Count on Central Line-Associated Bloodstream Infection in Children With Acute Lymphoblastic and Myeloid Leukemia.围手术期绝对中性粒细胞计数对急性淋巴细胞白血病和髓系白血病患儿中心静脉导管相关血流感染的影响
Front Oncol. 2021 Nov 23;11:770698. doi: 10.3389/fonc.2021.770698. eCollection 2021.
2
The risk of bloodstream infection associated with totally implantable venous access ports in cancer patient: a systematic review and meta-analysis.癌症患者完全植入式静脉输液港相关血流感染的风险:系统评价和荟萃分析。
Support Care Cancer. 2020 Jan;28(1):361-372. doi: 10.1007/s00520-019-04809-x. Epub 2019 May 2.
3
Reduced central line infection rates in children with leukemia following caregiver training: A quality improvement study.
照顾者培训后白血病患儿中心静脉导管感染率降低:一项质量改进研究。
Medicine (Baltimore). 2016 Jun;95(25):e3946. doi: 10.1097/MD.0000000000003946.
4
Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?儿科癌症中心血流感染的监测——我们学到了什么以及如何继续前行?
GMS Hyg Infect Control. 2016 May 12;11:Doc11. doi: 10.3205/dgkh000271. eCollection 2016.
5
Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients.改良版布罗维阿克维护护理包对儿科癌症患者血流感染的影响。
GMS Hyg Infect Control. 2015 Nov 16;10:Doc15. doi: 10.3205/dgkh000258. eCollection 2015.
6
Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.
Pediatr Surg Int. 2012 Dec;28(12):1195-9. doi: 10.1007/s00383-012-3213-4. Epub 2012 Nov 23.
7
Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children.儿童急性淋巴细胞白血病诊断时中心静脉置管的安全性。
Pediatr Blood Cancer. 2012 Apr;58(4):498-502. doi: 10.1002/pbc.24010. Epub 2011 Dec 11.